| ETS - | ETS + | Total |
---|
PTEN loss | 19 | 43 | 62 |
RAS/ERK mutation | 8 | 0 | 8 |
APC mutation | 6 | 5 | 11 |
Total | 133 | 133 | 266 |
- A summary of the 266 tumors analyzed by Taylor et al.[22], Grasso et al. [6], and Baca et al. [23]. ETS status indicates presence (+) or absence (-) of an ERG rearrangement in Taylor et al. and either an ERG or ETV1 rearrangement in Grasso et al. and Baca et al. RAS/ERK mutation includes point mutations from all three studies or verified gene rearrangements resulting in transcript fusions in Grasso et al. or Baca et al. for HRAS, KRAS, NRAS, RAF1, ARAF, BRAF, MAP2K1, MAP2K2, MAPK1, or MAPK3. APC mutations are included as a control to show that low frequency mutations are not always enriched in one category.